Racial Disparities in Acute Stroke (ERDAS)

April 24, 2025 updated by: Frisullo Giovanni, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Analysis of Ethnic and Racial Disparities in Access to Acute Stroke Care in Italy: A Multicentric, Prospective Cohort Study

Ischemic stroke is one of the leading causes of mortality and disability worldwide. Although the prevalence of stroke is high globally, not all ethnic and racial groups are affected in the same way, leading to the classification of stroke as an inequitable disease.

First of all, ethnic and racial background influences the pathogenesis of stroke, as numerous risk factors-both modifiable and non-modifiable-are more prevalent in Black and Hispanic populations compared to Asian ones. As a direct consequence, the incidence of stroke is higher in Black and Hispanic individuals than in White individuals. Unfortunately, despite this, access to revascularization treatments is not always guaranteed for ethnic and racial minorities, although in recent years, this inequality in access to care appears to be decreasing.

Moreover, stroke prognosis also seems to differ based on race/ethnicity, with mortality being higher among Black individuals compared to White individuals, although this trend tends to decrease with advancing age. On the other hand, although cerebral hemorrhage is more prevalent in Black and Asian populations than in White populations, it tends to have a better prognosis in these minority groups.

It must be considered, however, that the vast majority of studies on this topic have been conducted in the United States, where the ethnic and racial composition of the population is very different from that of Italy and Europe. In these latter contexts, studies investigating the impact of race and/or ethnicity on the clinical characteristics, management, and prognosis of ischemic stroke are lacking. Furthermore, differences in healthcare system organization may play a significant role in limiting access to timely and appropriate medical care for acute stroke based on race and/or ethnicity.

Italy is a country where, similarly to other European nations, the last few decades have seen a significant increase in immigration rates, particularly from Eastern Europe. Today, foreigners account for approximately 9% of the total population. Nevertheless, in Italy, systemic racism toward ethnic and racial minorities remains a significant issue, as evidenced by large disparities in educational attainment, socioeconomic status, and housing conditions between Italian citizens and foreign residents.

Although the universal national healthcare system in Italy should ensure equal access to care and emergency treatment for all, regardless of ethnic and racial background, there are no studies investigating this topic. A recent scoping review highlighted how individual racism plays a primary role in generating health inequalities, whereas there is very limited evidence focused on the analysis of structural and institutional racism in the Italian and European context.

As a consequence, this study aims to prospectively investigate the presence and the extent of racial and ethnic disparities in access to stroke care and treatment across several Italian comprehensive stroke centers.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

4500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bologna, Italy, 40124
        • Ospedale Maggiore, IRCCS Istituto delle Scienze Neurologiche di Bologna - UO Neurologia OM e Rete Stroke Metropolitana (SC)
      • Bologna, Italy, 40124
        • UOS Neurologia-AOU, IRCCS Istituto delle scienze Neurologiche
      • Crema, Italy, 26013
        • UOC Neurologia, ASST Crema
      • Frosinone, Italy, 03100
        • UOC Neurologia - Ospedale Spaziani
      • Genova, Italy, 16132
        • IRCCS Ospedale Policlinico San Martino
      • Lecce, Italy, 73100
        • Ospedale Vito Fazzi
      • Naples, Italy, 80131
        • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli
      • Pavia, Italy, 27100
        • Fondazione IRCCS Policlinico San Matteo
      • Pavia, Italy, 27100
        • IRCCS Fondazione Istituto Neurologico C. Mondino
      • Pozzilli, Italy, 86077
        • IRCCS Istituto Neurologico Mediterraneo Neuromed
      • Roma, Italy, 00133
        • Policlinico Tor Vergata
      • Rome, Italy, 00161
        • Policlinico Umberto I
      • Rome, Italy, 00168
        • Fondazione Policlinico Universitario A. Gemelli IRCCS
      • Rozzano, Italy, 20089
        • Humanitas Research Hospital IRCCS
      • Viterbo, Italy, 01100
        • UOC Neurologia Belcolle - Ospedale Belcolle

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients presenting to the ED of a hospital for a suspected stroke diagnosis. Patients will be then divided into different subgroups according to their racial/ethnic belonging (White, Asian, Hispanic, Black, Others).

Description

Inclusion Criteria:

  • Adults (≥18 years old);
  • Admission to the Emergency Department of the participating center with a diagnosis of ischemic stroke, as defined by the International Classification of Diseases, 9th Revision (ICD-9) codes;
  • Signed informed consent provided by the patient or, in cases of impaired decision-making capacity, by their legal guardian/representative.

Exclusion Criteria:

  • Discharge diagnosis other than ischemic stroke;
  • Refusal to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients presenting to the ED for acute ischemic stroke
Patients will be divided into several subgroups based on their racial/ethnic belonging (Asian/Hispanic/Black/White/Others).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Racial/ethnic disparities in the access to revascularization treatments
Time Frame: Baseline
Comparison of the likelihood of undergoing revascularization treatments among patients from different racial and/or ethnic groups.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Racial/ethnic disparities in onset to door times
Time Frame: Baseline
Comparison of Onset-to-Door Time among patients from different racial and/or ethnic groups.
Baseline
Racial/ethnic disparities in door to needle times
Time Frame: From the time of ED admission at baseline to start of intravenous thrombolysis
Comparison of differences in Door-to-Needle Time (DTN) between patients from different racial and/or ethnic groups.
From the time of ED admission at baseline to start of intravenous thrombolysis
Racial/ethnic disparities in door to groin times
Time Frame: From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy
Comparison of differences in Door-to-Groin Time (DTG) between patients from different racial and/or ethnic groups.
From the time of ED admission at baseline to femoral puncture for mechanical thrombectomy
Racial/ethnic differences in mode of emergency department arrival
Time Frame: Baseline
Comparison of ED arrival modes (walk-in vs emergency medical services) among patients from different racial and/or ethnic groups.
Baseline
Racial/ethnic differences in the prevalence of cardiovascular risk factors
Time Frame: Baseline
Comparison of the prevalence of cerebrovascular risk factors among patients from different racial and/or ethnic groups.
Baseline
Racial/ethnic differences in onset symptoms of stroke
Time Frame: Baseline
Comparison of stroke clinical presentation patterns among patients from different racial and/or ethnic groups.
Baseline
Racial/ethnic differences in stroke pathogenesis
Time Frame: From enrollment to hospital discharge, up to 90-days from baseline
Comparison of stroke etiologies, classified according to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria, among patients from different racial and/or ethnic groups.
From enrollment to hospital discharge, up to 90-days from baseline
Racial/ethnic differences stroke outcome at discharge
Time Frame: From enrollment to hospital discharge, up to 90-days from baseline
Comparison of discharge modified Rankin Scale (mRS) scores among patients from different racial and/or ethnic groups.
From enrollment to hospital discharge, up to 90-days from baseline
Racial/ethnic differences in 3-month stroke outcome
Time Frame: From enrollment to the 3-month follow-up visit
Comparison of 3-month modified Rankin Scale (mRS) scores after acute ischemic stroke among patients from different racial and/or ethnic groups.
From enrollment to the 3-month follow-up visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Giovanni Frisullo, Fondazione Policlinico Universitario A. Gemelli, IRCCS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2025

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

January 15, 2027

Study Registration Dates

First Submitted

April 16, 2025

First Submitted That Met QC Criteria

April 24, 2025

First Posted (Actual)

May 2, 2025

Study Record Updates

Last Update Posted (Actual)

May 2, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemic Stroke

Subscribe